The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21.20 - Manufacture of pharmaceutical preparations
300 jobs Number of planned job losses
Announcement Date
5 June 2019
Employment effect (start)
5 June 2019
Foreseen end date
Description
The German pharmaceutical company IDT Biologika will be cutting up to 300 jobs at its site in Dessau-Roßlau due to internal restructuring. The job reduction is part of a major restructuring programme, which includes the sale of the company’s animal health division by 1 July 2019. The company plans to reduce its number of employees from 1,900 to 1,600. A timeframe for the planned cuts has yet to be announced. The company intends to make this job reduction as socially acceptable as possible. This will be achieved via early-retirement programmes and not extending the contracts of temporary workers.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
